Italian field studies show that vaccination against Actinobacillus
pleuropneumoniae (App) is useful even when the mortality due to
App is low. Vaccination leads to increased profitability by improving
several production parameters.
To view this article in full click on the
pdf link below.
To comment, login here
Or register to be able to comment.